Post by
CrazyProphet on Feb 02, 2022 2:48pm
Blastoff is near
and so is FDA 3rd phase approval !!!
Comment by
1ottrunner on Feb 02, 2022 3:31pm
Judging from the number of shareholders willing to let go at this SP it seems most do not agree. FDA Approval, according to MF's timeline, wouldn't be before mid May. Consider this, if the trial was looking OH SO POSITIVE at dose selection, might they not have applied for EUA then? So, why didn't they?
Comment by
Trippedstocks on Feb 02, 2022 3:45pm
the math says they needed more placebo participants. Depending on hospitalization rate of placebo and if buci was 0%, they needed about a minimum of 200 placebo for 80% blah blah blah... Alpha, blah blah. Etc. But at 400 analysis and dose selection they only had 133 placebo. Then to compare at 600 there would have been 233 placebo.